Publikationen, an denen er mitarbeitet Javier Zulueta Frances (34)

2024

  1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  2. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

    Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490

  3. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

2021

  1. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

    ERJ Open Research, Vol. 7, Núm. 2, pp. 00773-2020

  2. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

2020

  1. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

  2. Prevalence and burden of bronchiectasis in a lung cancer screening program

    PLoS ONE, Vol. 15, Núm. 4

2019

  1. The prevalence of obstructive lung disease in a lung cancer screening cohort: Analysis of the national lung screening trial–American College of radiology image network cohort

    Annals of the American Thoracic Society

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

2015

  1. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

2013

  1. Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease

    PLoS ONE, Vol. 8, Núm. 6

  2. Lung cancer screening with low-radiation dose computed tomography after liver transplantation

    Annals of Transplantation, Vol. 18, Núm. 1, pp. 587-592

  3. Smokers with CT Detected Emphysema and No Airway Obstruction Have Decreased Plasma Levels of EGF, IL-15, IL-8 and IL-1ra

    PLoS ONE, Vol. 8, Núm. 4

2011

  1. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD

    Chest, Vol. 139, Núm. 1, pp. 36-42

  2. Evaluation of micro-CT for emphysema assessment in mice: Comparison with non-radiological techniques

    European Radiology, Vol. 21, Núm. 5, pp. 954-962

  3. FDG uptake and the diagnostic yield of transbronchial needle aspiration

    Journal of Bronchology and Interventional Pulmonology, Vol. 18, Núm. 1, pp. 7-14

  4. Robust, Standardized Quantification of Pulmonary Emphysema in Low Dose CT Exams

    Academic Radiology, Vol. 18, Núm. 11, pp. 1382-1390